Tillett, W.S. , Johnson, A.J., AND Mccarty, W.R.: Intravenous infusion of streptococcal fibrinolytic principle (streptokinase) into patients . J. Clin. Invest. , 34: 169, 1955.
2.
Johnson, A.J. , Fletcher, A.D., Mccarty , W.R., AND Tillet, W.S.: Effects in patients of intravenous infusions of purified streptokinase preparations. Proc. Soc. Exper. Biol. &Med., 94: 254, 1957.
3.
Cliffton, E.E. , Grossi, C.E., AND Cannamela , D.A.: Lysis of thrombi produced by sodium morrhurate in femoral vein of dogs of human plasmin (fibrinolysin) . Ann. Surg., 139: 52, 1954.
4.
Ambrus, J.C. , Ambrus, C.M., Bach, N., Sokal, J.E., AND Collins, G.L.: Clinical and experimental studies on fibrinolytic enzymes. Ann. New YorkAcad. Sc., 68: 97, 1957.
5.
Bach, N., Ambrus, J.C., Simpson, C.L., AND Shulman, S.: Study on effect of streptokinase-activated plasmin (fibrinolysin) on clots in various stages of organization. J. Clin. Invest. , 37: 864, 1958.
6.
Moser, K.M.: Thrombolysis with fibrinolysin (plasmin)—new therapeutic approach to thromboembolism. J. A. M. A., 167: 1695, 1958 .
7.
Cliffton, E.E. , AND Cannamela, D.A.: Fibrinolytic and proteolytic activity of a human "plasminogen" prepared from fraction III of human plasma . J. Appl. Physiol., 6: 42, 1953.
8.
Loomis, E.C. , George, C., JR., AND Byder , A.: Fibrinolysin: nomenclatures, unit, assay, preparations, and properties. Arch. Biochem.,12: 1, 1947.
9.
Troll, W., Sherry, S., AND Wachman, J.: The action of plasmin on synthetic substrates. J. Biol. Chem. , 208: 85, 1954.
10.
Astrup, T.: Biological significance of fibrinolysis. Lancet, 2: 565. 1956.
11.
Von Kaulla, K.N.: Intravenous protein-free pyrogen. Circulation, 17: 187, 1958.
12.
Moser, K.M. : Coagulation changes, systemic toxicity and fibrinolytic activity following intravenous infusion of fibrinolysin (plasmin) in humans. Circulation, in press.
